![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Zitzmann Michael
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.10, Iss.8, 2009-08, pp. : 1341-1349
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenetics and Smoking Cessation with Nicotine Replacement Therapy
By Ray Riju Schnoll Robert A. Lerman Caryn
CNS Drugs, Vol. 21, Iss. 7, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Risks of testosterone replacement therapy in ageing men
Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Testosterone replacement therapy: what are the risks?
Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)